2014

1. Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: Parallel study of 81 patients

   Leukemia and Lymphoma, Vol. 55, Núm. 10, pp. 2341-2348

2. Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: Final results of the PETHEMA ALL-AR-03 trial

   Journal of Clinical Oncology, Vol. 32, Núm. 15, pp. 1595-1604